Rivista di formazione e aggiornamento professionale del pediatra e del medico di base, dal 1982 In collaborazione con l'Associazione Culturale Pediatri

Caso contributivo

PDF MeBrain

Stiff-Baby Syndrome: quando pensarci. Il caso di Sofia

Stiff-Baby Syndrome

Paola Assandro1, Cecilia Sanesi2, Chiara Trevisol3, Laura Travan4
1Medico in formazione, IRCCS Materno-Infantile “Burlo Garofolo”, Trieste
2Fisioterapista, Neonatologia e Terapia Intensiva Neonatale, IRCCS Materno-Infantile “Burlo Garofolo”, Trieste
3Pediatra di base, ASL 002 Isontina
4Neonatologa, Neonatologia e Terapia Intensiva Neonatale, IRCCS Materno-Infantile “Burlo Garofolo”, Trieste

Dicembre 2013

Abstract
The Stiff-Baby Syndrome is a genetic startle disorder, presenting soon after birth and characterized by an exaggerated persistent startle response to unexpected stimuli and generalized muscular rigidity that decreases during sleep. Hyperekplexia is often mistakenly diagnosed as spastic quadriparesis or epilepsy, therefore it should be promptly identified during the neonatal period. Its treatment with benzodiazepines alleviates the debilitating symptoms, may prevent life-threatening events and enables better feeding and handling. The disorder is mainly due to hereditary mutations of the inhibitory postsynaptic neurotransmitter receptor (glycine receptor chloride channel), but in few cases the Stiff-Baby Syndrome is caused by sporadic missense and nonsense mutations. The diagnosis of such a relatively benign disorder with a favourable developmental outcome can avoid unjustified extensive investigations or unnecessary treatments. The article reports the case of a 3-month-old baby affected by a sporadic form of Stiff-Baby Syndrome.
Riassunto

La Stiff-Baby Syndrome (o hyperekplexia neonatale) è una malattia genetica a esordio neonatale, caratterizzata da un’eccessiva risposta motoria agli stimoli esogeni inaspettati (soprattutto di tipo acustico o tattile) e da una rigidità muscolare generalizzata che diminuisce o scompare durante il sonno. Tale patologia è spesso erroneamente scambiata per quadriparesi spastica o epilessia e dovrebbe essere rapidamente identificata già nei primi mesi di vita poiché il corretto trattamento delle forme severe con benzodiazepine è in grado di alleviare la sintomatologia ed evitare laringospasmo, difficoltà di suzione o - nei casi più gravi che coinvolgono il diaframma - eventi di morte improvvisa nel lattante. La malattia è principalmente causata da mutazioni ereditarie a carico del recettore inibitorio della glicina, ma in rari casi può essere associata a mutazioni missense o nonsense di tipo sporadico. La diagnosi di hyperekplexia neonatale permette di inquadrarla come patologia benigna a decorso favorevole, limitando pertanto approfondimenti diagnostici invasivi o trattamenti farmacologici inappropriati. Riportiamo il caso di una lattante di tre mesi e mezzo affetta dalla forma lieve di Stiff-Baby Syndrome.

Contenuto riservato

Per leggere l'articolo è necessario effettuare il login.

Per l'acquisto del singolo articolo scrivi a abbonamenti@medicoebambino.com (la mail si prepara da sola con gli estremi dell'articolo); se accedi, la richiesta parte con un click.

Bibliografia

  1. Vigevano F, Capua MD, Bernardina BD. Startle Disease: an avoidable cause of sudden infant death. The Lancet 1989;28:216.
  2. Tijssen MA, Vergouwe MN, van Dijk JG, Rees M, Frants RR, Brown P. Major and minor form of hereditary hyperekplexia. Mov Disord–2002;17:826-30.
  3. Bernasconi A, Regli F, Schorderet DF, Pescia G. Familial hyperekplexia: startle disease. Clinical, electrophysiological and genetic study of a family. Rev Neurol–1996;152:447-50.
  4. Suhren O, Bruyn GW, Tuynman JA. Hyperekplexia, a hereditary startle syndrome. J Neurol Sci–1966;3:577-605.
  5. Rivera S, Villega F, de Saint-Martin A, et al. Congenital hyperekplexia: five sporadic cases. Eur J Pediatr 2006;165:104-7.
  6. Rees MI, Andrew M, Jawad S, Owen MJ. Evidence for recessive as well as dominant forms of startle disease (hyperekplexia) caused by mutations in the alpha 1 subunit of the inhibitory glycine receptor. Hum Mol Genet 1994;3:2175-9.
  7. Shahar E,«Raviv R. Sporadic major hyperekplexia in neonates and infants: clinical manifestations and outcome. Pediatr Neurol–2004;31:30-4.
  8. Shan Q, Han L, Lynch JW. Function of hyperekplexia-causing α1R271Q/L glycine receptors is restored by shifting the affected residue out of the allosteric signaling pathway. Br J Pharmacol 2012;165:2113-23.
  9. Prechtl’HF, Cioni G,«Ferrari F, Paolicelli PB, Einspieler C, Roversi MF. Which better predicts later outcome in full-term infants: quality of general’movements’or neurological examination? Early Hum Dev 1997;50:71-85.
  10. Cioni G, Biagioni E, Bottai P, Castellacci AM, Paolicelli PB. Hyperekplexia and stiff-baby syndrome: an identical neurological disorder? Ital J Neurol Sci 1993;14:145-52.
  11. Gastaut H,«Villeneuve A. The startle disease or hyperekplexia. Pathological surprise reaction. J Neurol Sci–1967;5:523-42.
  12. Dreissen YE,«Tijssen MA. The startle syndromes: physiology and treatment. Epilepsia–2012;53:3-11.
  13. Andermann F, Keene DL, Andermann E, Quesney LF. Startle disease or hyperekplexia: further delineation of the syndrome. Brain 1980;103:985-7.
  14. Alajouanine T, Gastaut H. Synkinesis-startle and epilepsy startle triggered by unexpected sensory and sensitive factors. Anatomical and clinical data on 15 cases. Rev Neurol (Paris) 1955;93:29-41.
  15. Chaves-Carabello E. Syncope and paroxysmal disorders other than epilepsy. In: Pediatric neurology: Principles and Practice. 3rd ed. Mosby. USA, 1999:768-9.
  16. Kirstein L,«Silfverskiold BP. A family with emotionally precipitated drop seizures. Acta Psychiatr Neurol Scand–1958;33:471-6.
  17. Ryan SG,«Dixon MJ,«Nigro MA, et al. Genetic and radiation hybrid mapping of the hyperekplexia region on chromosome 5q. Am J Hum Genet–1992;51:1334-43.
  18. Rees’MI, Harvey K, Pearce BR, et al. Mutations in the gene encoding GlyT2 (SLC6A5) define a presynaptic component of human startle disease. Nat Genet–2006;38:801-6.
  19. Rees MI, Lewis TM, Kwok JB, et al. Hyperekplexia associated with compound heterozygote mutations in the beta-subunit of the human inhibitory glycine receptor (GLRB). Hum Mol Genet 2002;11:853-60.
  20. Rees MI, Harvey K, Ward H, et al. Isoform heterogeneity of the human gephyrin gene (GPHN), binding domains to the glycine receptor, and mutation analysis in hyperekplexia. J Biol Chem–2003;278:24688-96.
  21. Harvey K, Duguid IC, Alldred MJ, et al. The GDP-GTP exchange factor collybistin: an essential determinant of neuronal gephyrin clustering. J Neurosci–2004;24:5816-26.»
  22. Dalla Bernardina B, Fontana E, Colamaria V, La Selva L, Merlin D, Sgro V, Scarpa P. Neonatal hyperexplexia. In: Beaumanoir A, Gastaut H, Naquet R, Eds. Reflex Seizures and Reflex Epilepsies. Geneva, Switzerland: Editions Médicine et Hygiène, 1989:409-14.
  23. Pascotto A,«Coppola G. Neonatal’hyperekplexia: a case report. Epilepsia–1992;33:817-20.
  24. Koning-Tijssen MA, Brouwer OF. Hyperekplexia in the first year of life. Mov Disord–2000;15:1293-6.
  25. Praveen V, Patole SK, Whitehall JS. Hyperekplexia in neonates. Postgrad Med J 2001;77:570-2.
  26. Sharma SD, Sarna A, Mukhopadhyay S. Neonatal hyperekplexia: the Stiff-Baby syndrome. Indian Pediatr–2006;43:539-41.
  27. McAbee GN, Santilli AM, Stone J, Schnur RE.»Ectodermal, skeletal, and genitourinary abnormalities with neonatal hyperekplexia. Pediatr Neurol 2011;44:381-4.
  28. Tijssen MAJ,«Rees MI. Hyperekplexia. GeneReviews 2007 Bookshelf ID: NBK1260
  29. Tijssen MAJ, Rees MI. Hyperekplexia. GeneReviews, October 4, 2012.
  30. Rees MI, Lewis TM, Vafa B, et al. Compound heterozygosity and nonsense mutations in the alpha(1)-subunit of the inhibitory glycine receptor in hyperekplexia. Hum Genet–2001;109:267-70.
  31. Kurczynski TW. Hyperekplexia. Arch Neurol–1983;40:246-8.
  32. Shahar E, Brand N, Uziel Y, Barak Y. Nose tapping test inducing a generalized flexor spasm: a hallmark of hyperexplexia. Acta Paediatr Scand–1991;80:1073-7.
  33. Tohier C, Roze JC, David A, Veccierini MF, Renaud P, Mouzard A. Hyperexplexia or stiff baby syndrome. Arch Dis Child 1991;66:460-1.
  34. Bernasconi A, Cendes F, Showbridge EA, et al. Spectroscopic imaging of frontal neuronal dysfunction in hyperekplexia. Brain 1998;121:1507-12.
  35. Sahu JK,«Choudhary A,«Ghosh I, et al. Hyperekplexia masquerading as’epilepsy. Indian J Pediatr–2011;78:757.
  36. Warren JD,«Kimber TE,«Thompson PD. Brainstem myoclonus in generalised’tetanus. Mov Disord–2003;18:1204-6.
  37. Sander JE, Layzer RB, Goldsobel AB. Congenital stiffman syndrome. Ann Neurol 1980;8:195-7.
  38. Binnie CD. Simple reflex epilepsies. In: Engel J Jr, Pedley TA, eds. Epilepsy: a comprehensive textbook. Philadelphia: Lippincott-. Raven, 1998:2489-505.
  39. Stevens H. "Jumping Frenchmen of Maine". Myriiachita. Arch Neurol 1965;12:311-4.
  40. Giacoia GP, Ryan SG. Hyperekplexia associated with apnoea and sudden infant death syndrome. Arch Pediatr Adolesc Med 1994;148:540-3.
  41. Gordon N. Startle disease or hyperekplexia. Dev Med Child Neurol 1993;35:1015-8.
  42. Nigro MA, Lim HCN. Hyperekplexia and sudden neonatal death. Pediatr Neurol 1992;8:221-5.
  43. Hunt CT. The cardiorespiratory control hypothesis for sudden infant death syndrome. Clin Perinatol 1992;19:757-71.
  44. McAbee GN, Kadakia SK, Sisley KC, Delfiner JS. Complete heart block in non-familial hyperekplexia. Pediatr Neurol 1995;12:149-51.
  45. Thomas NJP, Thomas RH, Chung SK, Hammond CL, Robinson A, Rees MI. Missing genes in hyperekplexia. Welsh Paed J 2010;33:48.
  46. McMaster P, Cadzow S, Vince J, Appleton B. Hyperekplexia: a rare differential diagnosis of neonatal fits described in a developing country. Ann Trop Paediatr 1999;19:345-8.
  47. Ryan SG, Sherman SL, Terry JC, Sparkes RS, Torres MC, Mackey RW.»Startle disease, or hyperekplexia: response to clonazepam and assignment of the gene (STHE) to chromosome 5q by linkage analysis. Ann Neurol–1992;31:663-8.
  48. Volpe JJ, eds. Neurology of the newborn. 3rd Ed. Philadelphia: WB Saunders, 1995:189.